222 related articles for article (PubMed ID: 25403263)
21. Control of an H1N1 outbreak in a correctional facility in central Taiwan.
Chao WC; Liu PY; Wu CL
J Microbiol Immunol Infect; 2017 Apr; 50(2):175-182. PubMed ID: 26051221
[TBL] [Abstract][Full Text] [Related]
22. Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit.
Yue MC; Collins JT; Subramoniapillai E; Kennedy GA
Asia Pac J Clin Oncol; 2017 Feb; 13(1):37-43. PubMed ID: 27730741
[TBL] [Abstract][Full Text] [Related]
23. The effect of timing of oseltamivir chemoprophylaxis in controlling influenza A H3N2 outbreaks in long-term care facilities in Manitoba, Canada, 2014-2015: a retrospective cohort study.
Singh D; Jiang D; Van Caeseele P; Loeppky C
Infect Control Hosp Epidemiol; 2018 Aug; 39(8):955-960. PubMed ID: 29893659
[TBL] [Abstract][Full Text] [Related]
24. The Prophylactic Effect of Anti-influenza Agents for an Influenza Outbreak in a University Hospital.
Hagihara M; Kato Y; Kurumiya A; Takahashi T; Sakata M; Kato H; Sakanashi D; Yamada A; Suematsu H; Hirai J; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
Intern Med; 2018; 57(4):497-501. PubMed ID: 29445061
[TBL] [Abstract][Full Text] [Related]
25. Laboratory-confirmed influenza B infection in immunized long-term care facility residents receiving oseltamivir prophylaxis in Ontario.
Winter AL; Peci A; Eshaghi A; Baird M; Memari N; Kristjanson E; Balogun E; Higgins RR; Li A; Farrell DJ; Gubbay JB
Infect Control Hosp Epidemiol; 2013 Nov; 34(11):1225-8. PubMed ID: 24113612
[TBL] [Abstract][Full Text] [Related]
26. Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home.
Lee C; Loeb M; Phillips A; Nesbitt J; Smith K; Fearon M; McArthur MA; Mazzulli T; Li Y; McGeer A
Infect Control Hosp Epidemiol; 2000 Nov; 21(11):700-4. PubMed ID: 11089653
[TBL] [Abstract][Full Text] [Related]
27. [Practice guideline 'Influenza prevention in nursing homes and care homes', issued by the Dutch Society of Nursing Home Specialists; division of tasks between nursing home specialist, general practitioner and company doctor].
Cools HJ; van Essen GA;
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):119-24; discussion 116-8. PubMed ID: 15693586
[TBL] [Abstract][Full Text] [Related]
28. Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population.
Ambrozaitis A; Gravenstein S; van Essen GA; Rubinstein E; Balciuniene L; Stikleryte A; Crawford C; Elliott M; Shult P
J Am Med Dir Assoc; 2005; 6(6):367-74. PubMed ID: 16286057
[TBL] [Abstract][Full Text] [Related]
29. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks.
Lee VJ; Yap J; Cook AR; Chen MI; Tay JK; Tan BH; Loh JP; Chew SW; Koh WH; Lin R; Cui L; Lee CW; Sung WK; Wong CW; Hibberd ML; Kang WL; Seet B; Tambyah PA
N Engl J Med; 2010 Jun; 362(23):2166-74. PubMed ID: 20558367
[TBL] [Abstract][Full Text] [Related]
30. Oseltamivir for control of influenza at mass gatherings.
Tashani M; Rashid H; Ridda I; Heron L; Memish ZA; Haworth E; Booy R
Infect Disord Drug Targets; 2013 Feb; 13(1):46-52. PubMed ID: 23675926
[TBL] [Abstract][Full Text] [Related]
31. Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities.
Risebrough NA; Bowles SK; Simor AE; McGeer A; Oh PI
J Am Geriatr Soc; 2005 Mar; 53(3):444-51. PubMed ID: 15743287
[TBL] [Abstract][Full Text] [Related]
32. A model-based assessment of oseltamivir prophylaxis strategies to prevent influenza in nursing homes.
van den Dool C; Hak E; Bonten MJ; Wallinga J
Emerg Infect Dis; 2009 Oct; 15(10):1547-55. PubMed ID: 19861044
[TBL] [Abstract][Full Text] [Related]
33. Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study.
Vu D; Peck AJ; Nichols WG; Varley C; Englund JA; Corey L; Boeckh M
Clin Infect Dis; 2007 Jul; 45(2):187-93. PubMed ID: 17578777
[TBL] [Abstract][Full Text] [Related]
34. Emergence and transmission of amantadine-resistant influenza A in a nursing home.
Schilling M; Gravenstein S; Drinka P; Cox N; Krause P; Povinelli L; Shult P
J Am Geriatr Soc; 2004 Dec; 52(12):2069-73. PubMed ID: 15571544
[TBL] [Abstract][Full Text] [Related]
35. [Effect of post-exposure prophylaxis with oseltamivir for those in contacts with influenza patients in pediatric wards].
Shinjoh M; Sato S; Sugaya N; Mitamura K; Takeuchi Y; Kosaki K; Takahashi T
Kansenshogaku Zasshi; 2004 Mar; 78(3):262-9. PubMed ID: 15103909
[TBL] [Abstract][Full Text] [Related]
36. Influenza A/H1N1/2009 outbreak in a neonatal intensive care unit.
Tsagris V; Nika A; Kyriakou D; Kapetanakis I; Harahousou E; Stripeli F; Maltezou H; Tsolia M
J Hosp Infect; 2012 May; 81(1):36-40. PubMed ID: 22463979
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of Oseltamivir Prophylaxis in Influenza Outbreaks in Residential Aged Care.
Dronavalli M; Lord H; Alexander K; Boonwaat L; Pal N; Fletcher-Lartey SM
J Epidemiol Glob Health; 2020 Jun; 10(2):184-189. PubMed ID: 32538036
[TBL] [Abstract][Full Text] [Related]
38. Outbreaks of influenza-like illness in care homes in the East of England: impact of variations in neuraminidase inhibitor provision.
Yip JLY; Kapadia S; Ahmed A; Millership S
Public Health; 2018 Sep; 162():98-103. PubMed ID: 29990618
[TBL] [Abstract][Full Text] [Related]
39. Emergence of rimantadine-resistant virus within 6 days of starting rimantadine prophylaxis with oseltamivir treatment of symptomatic cases.
Drinka PJ; Haupt T
J Am Geriatr Soc; 2007 Jun; 55(6):923-6. PubMed ID: 17537095
[TBL] [Abstract][Full Text] [Related]
40. Preparing for pandemic influenza: should hospitals stockpile oseltamivir?
Cinti S; Chenoweth C; Monto AS
Infect Control Hosp Epidemiol; 2005 Nov; 26(11):852-4. PubMed ID: 16320980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
